Low genetic diversity in the locus encoding the Plasmodium vivax P41 protein in Colombia's parasite population

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Forero Rodríguez, Johanna ^a,b   Garzón Ospina, Diego ^a,c   Patarroyo, Manuel A ^a,c  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^c UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

6 Cys; Anti malarial vaccine; Functional constraint; Genetic variability; Plasmodium vivax; pv41; s48 45 domains

Indexed keywords

PLASMODIUM VIVAX P41 PROTEIN; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG; PROTOZOAL DNA;

ARTICLE; CLINICAL ARTICLE; CODON; COLOMBIA; COLOMBIAN; DNA POLYMORPHISM; DNA SEQUENCE; ELECTROPHORESIS; GENE ISOLATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC RECOMBINATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAURITANIAN; MOLECULAR EVOLUTION; NATURAL SELECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOUTH KOREAN; GENETIC SELECTION; GENETICS; ISOLATION AND PURIFICATION; MALARIA, VIVAX; MOLECULAR GENETICS; PARASITOLOGY; SEQUENCE ALIGNMENT;

BASE SEQUENCE; COLOMBIA; DNA, PROTOZOAN; GENETIC VARIATION; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALARIA, VIVAX; MOLECULAR SEQUENCE DATA; PLASMODIUM VIVAX; PROTOZOAN PROTEINS; SELECTION, GENETIC; SEQUENCE ALIGNMENT;

EID: 84908089833     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-388     Document Type: Article

References (60)

1. WHO, World Malaria Report 2013 Geneva: World Health Organization 2013 http://www.who.int/malaria/publications/world-malaria-report-2013/wmr2013-no-profiles.pdf
2. Malaria vaccine: candidate antigens, mechanisms, constraints and prospects. Carvalho LJ, Daniel-Ribeiro CT, Goto H, Scand J Immunol 2002 56 327 343 10.1046/j.1365-3083.2002.01160.x 12234254
3. Malaria vaccine development. Jones TR, Hoffman SL, Clin Microbiol Rev 1994 7 303 310 7923051
4. Vaccines against Plasmodium vivax: a research challenge. Patarroyo MA, Calderon D, Moreno-Perez DA, Expert Rev Vaccines 2012 11 1249 1260 10.1586/erv.12.91 23176656
5. Plasmodium vivax synonymous substitution frequencies, evolution and population structure deduced from diversity in AMA 1 and MSP 1 genes. Figtree M, Pasay CJ, Slade R, Cheng Q, Cloonan N, Walker J, Saul A, Mol Biochem Parasitol 2000 108 53 66 10.1016/S0166-6851(00)00204-8 10802318
6. Genetic diversity and selection in three Plasmodium vivax merozoite surface protein 7 (Pvmsp-7) genes in a Colombian population. Garzon-Ospina D, Lopez C, Forero-Rodriguez J, Patarroyo MA, PLoS One 2012 7 45962 10.1371/journal.pone.0045962 23049905
7. High polymorphism in Plasmodium vivax merozoite surface protein-5 (MSP5). Gomez A, Suarez CF, Martinez P, Saravia C, Patarroyo MA, Parasitology 2006 133 661 672 10.1017/S0031182006001168 16978450
8. Genetic polymorphism and natural selection in the C-terminal 42 kDa region of merozoite surface protein-1 among Plasmodium vivax Korean isolates. Kang JM, Ju HL, Kang YM, Lee DH, Moon SU, Sohn WM, Park JW, Kim TS, Na BK, Malar J 2012 11 206 10.1186/1475-2875-11-206 22709605
9. Molecular evolution and intragenic recombination of the merozoite surface protein MSP-3alpha from the malaria parasite Plasmodium vivax in Thailand. Mascorro CN, Zhao K, Khuntirat B, Sattabongkot J, Yan G, Escalante AA, Cui L, Parasitology 2005 131 25 35 10.1017/S0031182005007547 16038393
10. High sequence diversity and evidence of balancing selection in the Pvmsp3alpha gene of Plasmodium vivax in the Venezuelan Amazon. Ord R, Polley S, Tami A, Sutherland CJ, Mol Biochem Parasitol 2005 144 86 93 10.1016/j.molbiopara.2005.08.005 16159677
11. Intragenic recombination in the 3′ portion of the merozoite surface protein 1 gene of Plasmodium vivax. Putaporntip C, Jongwutiwes S, Seethamchai S, Kanbara H, Tanabe K, Mol Biochem Parasitol 2000 109 111 119 10.1016/S0166-6851(00)00238-3 10960170
12. Genetic diversity of the Plasmodium vivax merozoite surface protein-5 locus from diverse geographic origins. Putaporntip C, Udomsangpetch R, Pattanawong U, Cui L, Jongwutiwes S, Gene 2010 456 24 35 10.1016/j.gene.2010.02.007 20178839
13. Progress and challenges for malaria vaccines. Richie TL, Saul A, Nature 2002 415 694 701 10.1038/415694a 11832958
14. Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'. Takala SL, Plowe CV, Parasite Immunol 2009 31 560 573 10.1111/j.1365-3024.2009.01138.x 19691559
15. Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection. Polley SD, Tetteh KK, Lloyd JM, Akpogheneta OJ, Greenwood BM, Bojang KA, Conway DJ, J Infect Dis 2007 195 279 287 10.1086/509806 17191173
16. Understanding the population genetics of Plasmodium vivax is essential for malaria control and elimination. Arnott A, Barry AE, Reeder JC, Malar J 2012 11 14 10.1186/1475-2875-11-14 22233585
17. Identification of conserved erythrocyte binding regions in members of the Plasmodium falciparum Cys6 lipid raft-associated protein family. Garcia J, Curtidor H, Pinzon CG, Vanegas M, Moreno A, Patarroyo ME, Vaccine 2009 27 3953 3962 10.1016/j.vaccine.2009.04.039 19389446
18. Detergent-resistant erythrocyte membrane rafts are modified by a Plasmodium falciparum infection. Nagao E, Seydel KB, Dvorak JA, Exp Parasitol 2002 102 57 59 10.1016/S0014-4894(02)00143-1 12615167
19. Distinct protein classes including novel merozoite surface antigens in Raft-like membranes of Plasmodium falciparum. Sanders PR, Gilson PR, Cantin GT, Greenbaum DC, Nebl T, Carucci DJ, McConville MJ, Schofield L, Hodder AN, Yates JR 3rd, Crabb BS, J Biol Chem 2005 280 40169 40176 10.1074/jbc.M509631200 16203726
20. Gamma interferon levels and antibody production induced by two PvMSP-1 recombinant polypeptides are associated with protective immunity against P. vivax in Aotus monkeys. Barrero CA, Delgado G, Sierra AY, Silva Y, Parra-Lopez C, Patarroyo MA, Vaccine 2005 23 4048 4053 10.1016/j.vaccine.2005.02.012 15893858
21. The future for blood-stage vaccines against malaria. Richards JS, Beeson JG, Immunol Cell Biol 2009 87 377 390 10.1038/icb.2009.27 19417768
22. The Plasmodium vivax Pv41 surface protein: identification and characterization. Angel DI, Mongui A, Ardila J, Vanegas M, Patarroyo MA, Biochem Biophys Res Commun 2008 377 1113 1117 10.1016/j.bbrc.2008.10.129 18983983
23. Characterisation of the Plasmodium vivax Pv38 antigen. Mongui A, Angel DI, Guzman C, Vanegas M, Patarroyo MA, Biochem Biophys Res Commun 2008 376 326 330 10.1016/j.bbrc.2008.08.163 18789893
24. The GPI-anchored 6-Cys protein Pv12 is present in detergent-resistant microdomains of Plasmodium vivax blood stage schizonts. Moreno-Perez DA, Areiza-Rojas R, Florez-Buitrago X, Silva Y, Patarroyo ME, Patarroyo MA, Protist 2013 164 37 48 10.1016/j.protis.2012.03.001 22554829
25. Biochemical and functional analysis of two Plasmodium falciparum blood-stage 6-cys proteins: P12 and P41. Taechalertpaisarn T, Crosnier C, Bartholdson SJ, Hodder AN, Thompson J, Bustamante LY, Wilson DW, Sanders PR, Wright GJ, Rayner JC, Cowman AF, Gilson PR, Crabb BS, PLoS One 2012 7 41937 10.1371/journal.pone.0041937 22848665
26. Structural and biochemical characterization of Plasmodium falciparum 12 (Pf12) reveals a unique interdomain organization and the potential for an antiparallel arrangement with Pf41. Tonkin ML, Arredondo SA, Loveless BC, Serpa JJ, Makepeace KA, Sundar N, Petrotchenko EV, Miller LH, Grigg ME, Boulanger MJ, J Biol Chem 2013 288 12805 12817 10.1074/jbc.M113.455667 23511632
27. Characterization of a novel merozoite surface protein of Plasmodium vivax, Pv41. Cheng Y, Lu F, Tsuboi T, Han ET, Acta Trop 2013 126 222 228 10.1016/j.actatropica.2013.03.002 23499861
28. Immunoproteomics profiling of blood stage Plasmodium vivax infection by high-throughput screening assays. Chen JH, Jung JW, Wang Y, Ha KS, Lu F, Lim CS, Takeo S, Tsuboi T, Han ET, J Proteome Res 2010 9 6479 6489 10.1021/pr100705g 20949973
29. Low genetic diversity and functional constraint in loci encoding Plasmodium vivax P12 and P38 proteins in the Colombian population. Forero-Rodriguez J, Garzon-Ospina D, Patarroyo MA, Malar J 2014 13 58 10.1186/1475-2875-13-58 24533461
30. Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1. Imwong M, Pukrittayakamee S, Gruner AC, Renia L, Letourneur F, Looareesuwan S, White NJ, Snounou G, Malar J 2005 4 20 10.1186/1475-2875-4-20 15854233
31. The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparum. Neafsey DE, Galinsky K, Jiang RH, Young L, Sykes SM, Saif S, Gujja S, Goldberg JM, Young S, Zeng Q, Chapman SB, Dash AP, Anvikar AR, Sutton PL, Birren BW, Escalante AA, Barnwell JW, Carlton JM, Nat Genet 2012 44 1046 1050 10.1038/ng.2373 22863733
32. The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites. Bozdech Z, Mok S, Hu G, Imwong M, Jaidee A, Russell B, Ginsburg H, Nosten F, Day NP, White NJ, Carlton JM, Preiser PR, Proc Natl Acad Sci U S A 2008 105 16290 16295 10.1073/pnas.0807404105 18852452
33. Timing the origin of human malarias: the lemur puzzle. Pacheco MA, Battistuzzi FU, Junge RE, Cornejo OE, Williams CV, Landau I, Rabetafika L, Snounou G, Jones-Engel L, Escalante AA, BMC Evol Biol 2011 11 299 10.1186/1471-2148-11-299 21992100
34. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Edgar RC, Nucleic Acids Res 2004 32 1792 1797 10.1093/nar/gkh340 15034147
35. PAL2NAL: robust conversion of protein sequence alignments into the corresponding codon alignments. Suyama M, Torrents D, Bork P, Nucleic Acids Res 2006 34 609 W612 10.1093/nar/gkl315 16845082
36. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Librado P, Rozas J, Bioinformatics 2009 25 1451 1452 10.1093/bioinformatics/btp187 19346325
37. Neutrality tests based on the distribution of haplotypes under an infinite-site model. Depaulis F, Veuille M, Mol Biol Evol 1998 15 1788 1790 10.1093/oxfordjournals.molbev.a025905 9917213
38. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Tajima F, Genetics 1989 123 585 595 2513255
39. Statistical tests of neutrality of mutations. Fu YX, Li WH, Genetics 1993 133 693 709 8454210
40. Hitchhiking under positive Darwinian selection. Fay JC, Wu CI, Genetics 2000 155 1405 1413 10880498
41. Statistical tests of neutrality of mutations against population growth, hitchhiking and background selection. Fu YX, Genetics 1997 147 915 925 9335623
42. Positive Darwinian selection after gene duplication in primate ribonuclease genes. Zhang J, Rosenberg HF, Nei M, Proc Natl Acad Sci U S A 1998 95 3708 3713 10.1073/pnas.95.7.3708 9520431
43. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S, Mol Biol Evol 2011 28 2731 2739 10.1093/molbev/msr121 21546353
44. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Kosakovsky Pond SL, Frost SD, Mol Biol Evol 2005 22 1208 1222 10.1093/molbev/msi105 15703242
45. Adaptation to different human populations by HIV-1 revealed by codon-based analyses. Pond SL, Frost SD, Grossman Z, Gravenor MB, Richman DD, Brown AJ, PLoS Comput Biol 2006 2 62 10.1371/journal.pcbi.0020062 16789820
46. Detecting individual sites subject to episodic diversifying selection. Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K, Kosakovsky Pond SL, PLoS Genet 2012 8 1002764 10.1371/journal.pgen.1002764 22807683
47. FUBAR: a fast, unconstrained bayesian approximation for inferring selection. Murrell B, Moola S, Mabona A, Weighill T, Sheward D, Kdosakovsky Pond SL, Scheffler K, Mol Biol Evol 2013 30 1196 1205 10.1093/molbev/mst030 23420840
48. Adaptive protein evolution at the Adh locus in Drosophila. McDonald JH, Kreitman M, Nature 1991 351 652 654 10.1038/351652a0 1904993
49. Standard and generalized McDonald-Kreitman test: a website to detect selection by comparing different classes of DNA sites. Egea R, Casillas S, Barbadilla A, Nucleic Acids Res 2008 36 157 W162 10.1093/nar/gkn337 18515345
50. Evolution of Protein Molecules. Jukes THCRC, Mammalian Protein Metabolism New York: Academic Press, Munro HN, 1969
51. A test of neutrality based on interlocus associations. Kelly JK, Genetics 1997 146 1197 1206 9215920
52. DNA variation at the rp49 gene region of Drosophila simulans: evolutionary inferences from an unusual haplotype structure. Rozas J, Gullaud M, Blandin G, Aguade M, Genetics 2001 158 1147 1155 11454763
53. Statistical properties of the number of recombination events in the history of a sample of DNA sequences. Hudson RR, Kaplan NL, Genetics 1985 111 147 164 4029609
54. Automated phylogenetic detection of recombination using a genetic algorithm. Kosakovsky Pond SL, Posada D, Gravenor MB, Woelk CH, Frost SD, Mol Biol Evol 2006 23 1891 1901 10.1093/molbev/msl051 16818476
55. Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology. Delport W, Poon AF, Frost SD, Kosakovsky Pond SL, Bioinformatics 2010 26 2455 2457 10.1093/bioinformatics/btq429 20671151
56. Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivax. Doi M, Tanabe K, Tachibana S, Hamai M, Tachibana M, Mita T, Yagi M, Zeyrek FY, Ferreira MU, Ohmae H, Kaneko A, Randrianarivelojosia M, Sattabongkot J, Cao YM, Horii T, Torii M, Tsuboi T, Vaccine 2011 29 4308 4315 10.1016/j.vaccine.2011.04.028 21514344
57. Population genetic analysis of the Plasmodium falciparum 6-cys protein Pf38 in Papua New Guinea reveals domain-specific balancing selection. Reeder JC, Wapling J, Mueller I, Siba PM, Barry AE, Malar J 2011 10 126 10.1186/1475-2875-10-126 21569602
58. The evolutionary history of Plasmodium vivax as inferred from mitochondrial genomes: parasite genetic diversity in the Americas. Taylor JE, Pacheco MA, Bacon DJ, Beg MA, Machado RL, Fairhurst RM, Herrera S, Kim JY, Menard D, Povoa MM, Villegas L, Mulyanto, Snounou G, Cui L, Zeyrek FY, Escalante AA, Mol Biol Evol 2013 30 2050 2064 10.1093/molbev/mst104 23733143
59. Invasion of red blood cells by malaria parasites. Cowman AF, Crabb BS, Cell 2006 124 755 766 10.1016/j.cell.2006.02.006 16497586
60. Structure of the Plasmodium 6-cysteine s48/45 domain. Arredondo SA, Cai M, Takayama Y, MacDonald NJ, Anderson DE, Aravind L, Clore GM, Miller LH, Proc Natl Acad Sci U S A 2012 109 6692 6697 10.1073/pnas.1204363109 22493233